Walter Heindel1, Karin Bock2, Gerold Hecht3, Sylvia Heywang-Köbrunner4, Vanessa Kääb-Sanyal5, Katja Siegmann-Luz6, Stefanie Weigel7. 1. Klinik für Radiologie und Referenzzentrum Mammographie Münster, Universität Münster (WWU) und Universitätsklinikum Münster (UKM), Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland. heindel@uni-muenster.de. 2. Referenzzentrum Mammographie Südwest, Bahnhofstraße 7, 35037, Marburg, Deutschland. 3. Referenzzentrum Mammographie Nord, Heiligengeiststraße 28, 26121, Oldenburg, Deutschland. 4. Referenzzentrum Mammographie München, Sonnenstraße 29, 80331, München, Deutschland. 5. Geschäftsstelle der Kooperationsgemeinschaft Mammographie, Goethestraße 85, 10623, Berlin, Deutschland. 6. Referenzzentrum Mammographie Berlin, Straße des 17. Juni 106-108, 10623, Berlin, Deutschland. 7. Klinik für Radiologie und Referenzzentrum Mammographie Münster, Universität Münster (WWU) und Universitätsklinikum Münster (UKM), Albert-Schweitzer-Campus 1, Gebäude A1, 48149, Münster, Deutschland.
Abstract
BACKGROUND: A quality-assured mammography screening programme has been available since 2009, nationwide, to all women in Germany between the ages of 50 and 69. The programme is based on the European Guidelines. In this review article the authors summarize the current status of scientific assessments of this national early detection programme for breast cancer and provide an outlook regarding ongoing studies on effectiveness tests and further development. RESULTS: We expect a decline in mortality rates relating to breast cancer as a result of successfully bringing diagnoses forward and a decrease in advanced breast cancer after a repeated screening. The extent will be shown in the current ZEBra study on mortality evaluation. CONCLUSION: Potential for a further increase in the effectiveness of the systematic early detection of breast cancer can be identified in four areas: (1) More women should take advantage of the early detection opportunities offered by the medical insurance funds; so far, on average, only about 50% of the women between 50 and 69 who are entitled to a screening examination actually take part in the programme. (2) Entitlement to take part in the programme should be extended to women over 70. (3) The further development of digital mammography towards digital breast tomosynthesis promises to reduce the number of false positive recalls while at the same time increasing sensitivity. (4) There should be scientific studies relating to an extension of screening strategies for the small number of women in the entitlement range who have extremly dense breasts.
BACKGROUND: A quality-assured mammography screening programme has been available since 2009, nationwide, to all women in Germany between the ages of 50 and 69. The programme is based on the European Guidelines. In this review article the authors summarize the current status of scientific assessments of this national early detection programme for breast cancer and provide an outlook regarding ongoing studies on effectiveness tests and further development. RESULTS: We expect a decline in mortality rates relating to breast cancer as a result of successfully bringing diagnoses forward and a decrease in advanced breast cancer after a repeated screening. The extent will be shown in the current ZEBra study on mortality evaluation. CONCLUSION: Potential for a further increase in the effectiveness of the systematic early detection of breast cancer can be identified in four areas: (1) More women should take advantage of the early detection opportunities offered by the medical insurance funds; so far, on average, only about 50% of the women between 50 and 69 who are entitled to a screening examination actually take part in the programme. (2) Entitlement to take part in the programme should be extended to women over 70. (3) The further development of digital mammography towards digital breast tomosynthesis promises to reduce the number of false positive recalls while at the same time increasing sensitivity. (4) There should be scientific studies relating to an extension of screening strategies for the small number of women in the entitlement range who have extremly dense breasts.
Entities:
Keywords:
Advanced tumor stages; Breast cancer; Breast cancer-related mortality; Cancer registry; Quality-assured mammography screening program
Authors: Joy Melnikow; Joshua J Fenton; Evelyn P Whitlock; Diana L Miglioretti; Meghan S Weyrich; Jamie H Thompson; Kunal Shah Journal: Ann Intern Med Date: 2016-01-12 Impact factor: 25.391
Authors: Alexander Katalinic; Nora Eisemann; Klaus Kraywinkel; Maria R Noftz; Joachim Hübner Journal: Int J Cancer Date: 2019-12-04 Impact factor: 7.396
Authors: Emily F Conant; William E Barlow; Sally D Herschorn; Donald L Weaver; Elisabeth F Beaber; Anna N A Tosteson; Jennifer S Haas; Kathryn P Lowry; Natasha K Stout; Amy Trentham-Dietz; Roberta M diFlorio-Alexander; Christopher I Li; Mitchell D Schnall; Tracy Onega; Brian L Sprague Journal: JAMA Oncol Date: 2019-05-01 Impact factor: 31.777